Search results
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Study reveals role of neutrophil lipid transfer in lung cancer transition
Medical Xpress· 1 hour agoPhenotypic plasticity is a cancer hallmark, and lung adeno-to-squamous transition (AST) triggered by...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 5 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
HEALTHY LIVING: Men’s Health Month: Understand your risk for lung cancer | Siloam Springs...
Northwest Arkansas Democrat Gazette· 13 hours agoAccording to the American Lung Association, more men than women are diagnosed with lung cancer each...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 8 hours agoIn a recent study led by Suresh Ramalingam, MD, executive director of Winship Cancer Institute of Emory University, a new drug has shown remarkable promise in treating patients with a specific ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
City of Hope’s new blood test for lung cancer will mean more early detections
Los Angeles Daily News· 5 days agoTo test for lung cancer, a person needs to get low-dose computed tomography screening, more commonly...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 7 hours agoThe company's trials include AVANZAR, evaluating Dato-DXd plus Imfinzi for first-line treatment of...